Publications
Where expertise meets impact
Berry doesn’t just follow industry standards — we set them. Our team of award-winning statisticians, journal editors, and regulatory advisors leads the field in Bayesian and adaptive trial design. With research published in The New England Journal of Medicine, JAMA, and The Lancet, we’re driving innovation where it matters most.
Over 90% of our scientists published influential work this past year, advancing adaptive, Bayesian, and platform trial methodology. Our blend of academic rigor, regulatory insight, and real-world experience makes Berry a true authority in modern clinical trials.
Explore our most impactful peer-reviewed publications below.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Springer Nature
Infectious Disease
Meta-analysis
Corticosteroids for adult patients hospitalised with non-viral community-acquired pneumonia: a systematic review and meta-analysis
May 5, 2025
2025
DOI:10.1007/s00134-025-07912-2
Springer Nature
Infectious Disease
Platform
Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia : The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial
April 22, 2025
2025
DOI: 10.1007/s00134-025-07861-w
The Lancet Neurology
Neuroscience
Dose Ranging
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial
February 24, 2025
2025
DOI: 10.1016/S1474-4422(24)00456-3
Hepatology Communications
Rare Diseases
Data Analysis
Liver involvement in a large cohort of patients with erythropoietic protoporphyria or X-linked protoporphyria.
February 19, 2025
2025
DOI: 10.1097/HC9.0000000000000657
JAMA Neurology
Neuroscience
Platform
Verdiperstat in Amyotrophic Lateral Sclerosis Results From the Randomized HEALEY ALS Platform Trial
February 17, 2025
2025
doi:10.1001/jamaneurol.2024.5249
JAMA
Neuroscience
Platform
CNM-Au8 in Amyotrophic Lateral Sclerosis The HEALEY ALS Platform Trial
February 17, 2025
2025
doi:10.1001/jama.2024.27643
JAMA Network Open
Neuroscience
Platform
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis A Randomized Clinical Trial
February 17, 2025
2025
doi:10.1001/jamanetworkopen.2024.59058
JAMA
Neuroscience
Platform
Pridopidine in Amyotrophic Lateral Sclerosis The HEALEY ALS Platform Trial
February 17, 2025
2025
doi:10.1001/jama.2024.26429
No results found.
There are no results with this criteria. Try changing your search.